The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

SCLP SCANCELL HOLDINGS PLC ORD 0.1P




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
07:00 23-May-2018 SCLP Grant of European patent for Moditope platform RNS -1.51% Down
13:11 11-May-2018 SCLP Holding(s) in Company RNS +13.43% Up
10:12 09-May-2018 SCLP Holding(s) in Company RNS +11.09% Up
07:00 08-May-2018 SCLP Result of the Open Offer and PDMR Shareholdings RNS +8.57% Up
12:43 23-Apr-2018 SCLP Holding(s) in Company RNS -15.64% Down
16:32 20-Apr-2018 SCLP Holding(s) in Company RNS -19.32% Down
14:29 18-Apr-2018 SCLP Result of Placing and Subscription and PDMR RNS -23.15% Down
11:05 18-Apr-2018 SCLP Second Price Monitoring Extn RNS -23.15% Down
11:00 18-Apr-2018 SCLP Price Monitoring Extension RNS -23.15% Down
07:00 18-Apr-2018 SCLP Technology acquired from University of Nottingham RNS -23.15% Down
07:00 18-Apr-2018 SCLP Proposed Placing, Subscription and Open Offer RNS -23.15% Down
07:00 03-Apr-2018 SCLP Manufacturing agreement with The PolyPeptide Group RNS +5.45% Up
11:30 16-Feb-2018 SCLP Scancell to present at the Calculus Investor Forum RNS +3.49% Up
07:15 15-Feb-2018 SCLP Hardman Res. - Validating multiple opportunities RNS +7.54% Up
07:00 15-Feb-2018 SCLP Collaboration agreement with ISA Pharmaceuticals RNS +7.54% Up
07:00 12-Feb-2018 SCLP Publication highlights potential of SCIB1 therapy RNS +17.88% Up
07:00 09-Feb-2018 SCLP European patent application allowed for grant RNS +23.97% Up
07:00 08-Feb-2018 SCLP Scancell member of team shortlisted for CRUK award RNS +24.54% Up
07:00 01-Feb-2018 SCLP Director/PDMR Shareholding RNS -1.63% Down
07:00 30-Jan-2018 SCLP Half-year Report RNS -2.77% Down

 Page 1 of 2

| 1 | 2 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Market

Company Information
Updated Monthly
Company address John Eccles House, Robert Robinson Avenue, Oxford Science Park, Oxford, OX4 4GP, United Kingdom
Company website http://www.scancell.co....
Market cap(in millions)* £ 47.14
Listing/Admission to trading 30 Jul 2010
Trading service SETSqx
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
23-May-18
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment ASQ1
MiFID Status -
Exchange market size 10,000
SEDOL B63D331
ISIN number GB00B63D3314



SCANCELL HLDGS share news analysis (SCLP)